National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 387210

History of Changes from the VAERS Wayback Machine

First Appeared on 5/11/2010

VAERS ID: 387210
VAERS Form:
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 5/13/2013

VAERS ID: 387210 Before After
VAERS Form:
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 9/14/2017

VAERS ID: 387210 Before After
VAERS Form:(blank) 1
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 0 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 2/14/2018

VAERS ID: 387210 Before After
VAERS Form:1
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 6/14/2018

VAERS ID: 387210 Before After
VAERS Form:1
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 8/14/2018

VAERS ID: 387210 Before After
VAERS Form:1
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 9/14/2018

VAERS ID: 387210 Before After
VAERS Form:1
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.


Changed on 10/14/2018

VAERS ID: 387210 Before After
VAERS Form:1
Age:0.4
Sex:Male
Location:Foreign
Vaccinated:2010-03-12
Onset:2010-05-02
Submitted:2010-05-11
Entered:2010-05-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Echography abnormal, Inappropriate schedule of drug administration, Intussusception, Lymphadenopathy, Pyrexia, Rectal haemorrhage, Vomiting, Enema administration, Stool analysis abnormal, Adenovirus infection, Intestinal operation

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Echography, 02May2010, lymph nodes; Stool analysis, May2010, adenovirus
CDC 'Split Type': B0651961A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 6-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 5 February 2010 and 12 March 2010, the subject received 1st dose and 2nd dose of ROTARIX (route unknown, batch number not provided). On 2 May 2010, 51 days after vaccination with 2nd dose of ROTARIX and 86 days after vaccination with 1st dose of ROTARIX, the subject experienced ileocecal invagination of 12 cm, proctorrhagia, vomiting and lymphadenopathy (presence of lymph nodes confirmed via echography). The subject was hospitalised. He was treated with injection of contrast product (via rectum) to reduce the invagination but it was only partially successful. Then, he was operated in order to reduce completely the invagination which was fully successful without any resection of the intestine. On 3 May 2010, 52 days after vaccination with 2nd dose of ROTARIX and 87 days after vaccination with 1st dose of ROTARIX, the subject experienced fever. They excluded any post operation complication. On 4 May 2010, 53 days after vaccination with 2nd dose of ROTARIX and 88 days after vaccination with 1st dose of ROTARIX, the subject experienced diarrhea. A stool analysis was performed and showed the presence of adenovirus. At the time of reporting, the events were resolved. According to the pediatrician, this was a mechanical invagination due to the presence of lymph nodes. Further information has been expected.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=387210&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166